-
Andexanet alfa for the reversal of the low-molecular-weight heparin enoxaparin
van Haaps, T. F., Benz, A. P., Xu, L., Middeldorp, S., Eikelboom, J. W., Milling, T. J., Crowther, M., Holer, L., Nolan, S., Ladenvall, P. & ANNEXA-4 investigators, 1 Oct 2025, In: Research and practice in thrombosis and haemostasis. 9, 7, 103191.Research output: Contribution to journal › Article › Academic › peer-review
-
Discordance and bleeding in critically ill patients with COVID-19 receiving unfractionated heparin: A comparison between aPTT and anti-factor Xa activity level monitoring
Reuland, M. C., van Haaps, T. F., Broeren, P. O. L. P., van Es, N., Dijkslag-van der Laan, C. E., Vlaar, A. P. J., Coppens, M. & Müller, M. C. A., 1 Jun 2025, In: Thrombosis Update. 19, 100202.Research output: Contribution to journal › Article › Academic › peer-review
-
Blood-perfused Vessels-on-Chips stimulated with patient plasma recapitulate endothelial activation and microthrombosis in COVID-19
Weener, H. J., van Haaps, T. F., van Helden, R. W. J., Albers, H. J., Haverkate, R., Middelkamp, H. H. T., Ridderikhof, M. L., van Mens, T. E., van den Berg, A., Mummery, C. L., Orlova, V. V., Middeldorp, S., van Es, N. & van der Meer, A. D., 25 Feb 2025, In: Lab on a Chip. 25, 7, p. 1787-1800 14 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications